Elizabeth Eisenhauer

1 month ago | ejcancer.com | Elizabeth Eisenhauer |European Organization

KeywordsCritical appraisalrandomized cancer trialsGet full text accessLog in, subscribe or purchase for full access. References1. Booth, C.M. ∙ Sengar, M. ∙ Goodman, A. ... Common Sense Oncology: outcomes that matterLancet Oncol. 2023; 24:833-8352. Gyawali, B. ∙ Eisenhauer, E.A. ∙ van der Graaf, W. ... Common Sense Oncology principles for the design, analysis and reporting of phase III randomised clinical trialsLancet Oncol. 2025; 26:e80-e893. Cherny, N.I. ∙ Dafni, U. ∙ Bogaerts, J. ...

May 20, 2024 | jamanetwork.com | Brooke Wilson |Elizabeth Eisenhauer |Christopher Booth

Randomized clinical trials (RCTs) define the efficacy of new cancer treatments and drive changes in clinical practice. Although the role of RCTs in generating knowledge is universally accepted, the often-cited benefits of trial participation for individual patients is open for debate.